RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

1.94 USD
At close Jan 21, 4:00 PM EST
1 day
0.00%
5 days
0.00%
1 month
0.00%
3 months
0.00%
6 months
0.00%
Year to date
0.00%
1 year
0.00%
5 years
0.00%
10 years
0.00%
 

About: Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.

Employees: 3

Healthcare Pharmaceutical Preparations
0
Funds holding %
of 6,823 funds
–
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

10% more funds holding

Funds holding: 29 [Q2] → 32 (+3) [Q3]

10% more capital invested

Capital invested by funds: $14.8M [Q2] → $16.3M (+$1.5M) [Q3]

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for RNTX.

See Analyst Rankings

Financial journalist opinion

We haven’t received any recent news articles for RNTX.

See News Rankings
Charts implemented using Lightweight Charts™